Optimus generics R&D pipeline is focused on developing a comprehensive portfolio of complex & niche products that address unmet patient needs. We’ve continuously executed dossier filings and received approvals from across the globe including the USA, Europe & India. Our formulation R&D centre is DSIR approved, built as per global standards with dedicated infrastructure and technology to deliver high-quality products.
Formulation Development is the core competency of Optimus Pharma, and we routinely carry out the development of Generic formulations, Specialty and novel formulations, Consumer and Over-The-Counter (OTC) formulations with desired sensorial attributes, excipient application studies and placebo development.
Product development at Optimus begins with a product development strategy. Desired product attributes are identified, and prototype formulations are developed to meet the desired product attributes. Critical process parameters (CPP) are identified, and process optimization studies are carried out based on Quality by Design (QbD) principles. Based on the formula and process optimization studies, the final composition and manufacturing process is recommended for biostudy and scale-up.
We are proud of our research accomplishments and we look forward to many more R&D challenges in the future, with a great level of confidence and enthusiasm.